previous compound ID: 950 next compound
InChIKey: IKMDFBPHZNJCSN-UHFFFAOYSA-N
SMILES: C1=C(C=C(C(=C1O)O)O)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "B Kus" "J Liao" "JW Hanrahan" "D Rotin" "GW Carlile" "DY Thomas" "SD Macknight" "R Robert" "E Matthes"

chemical graph of compound 950





CID is 5281672
synonyms found at PubChem are:
myricetin, 529-44-2, Cannabiscetin, Myricetol, Myricitin, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one, 3,3',4',5,5',7-Hexahydroxyflavone, 3,5,7,3',4',5'-Hexahydroxyflavone, UNII-76XC01FTOJ, NSC 407290, CCRIS 5838, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one, EINECS 208-463-2, NSC407290, CHEMBL164, NSC-407290, BRN 0332331, 76XC01FTOJ, 3,3',4,4',5',7-Hexahydro-2-phenyl-4H-chromen-4-one, CHEBI:18152, FLAVONE, 3,3',4',5,5',7-HEXAHYDROXY-, MYC, Q-100601, SMR001233193, SR-01000076005, HSDB 7682, 4gqr, Prestwick_342, Spectrum_001501, SpecPlus_000531, AC1NQYV4, Prestwick0_000465, Prestwick1_000465, Prestwick2_000465, Prestwick3_000465, Spectrum4_001272, Spectrum5_000692, Lopac-M-6760, Myricetin (Cannabiscetin), Myricetin from Myrica cerifera leaf and bark, D0T3PW, BIDD:PXR0079, Lopac0_000740, SCHEMBL19302, BSPBio_000570, KBioGR_001884, KBioSS_001981, MLS002153825, MLS006010718, BIDD:ER0142, DivK1c_006627, Myricetin, analytical standard, SPBio_002509, BPBio1_000628, MEGxp0_000357, DTXSID8022400, ACon1_000267, BDBM15236, cid_5281672, KBio1_001571, KBio2_001981, KBio2_004549, KBio2_007117, KS-00000GOF, 2o63, CHEBI: 18152, IKMDFBPHZNJCSN-UHFFFAOYSA-N, MolPort-001-740-532, REGID_for_CID_5281672, HMS1569M12, HMS2096M12, HMS2231L04, HMS3262C22, HMS3656I05, BCP28295, Myricetin, >=96.0% (HPLC), Myricetin, >=96.0%, crystalline, TNP00286, ZINC3874317, Tox21_500740, AN-939, BBL023468, BS0289, CM0160, GL5441, LMPK12110001, MFCD00006827, Myricetin solution, 20 mM in DMSO, s2326, STL284709, 3,7,3',4',5'-Hexahydroxyflavone, AKOS015903103, AC-4533, CCG-204825, CS-6221, DB02375, KS-5268, LP00740, MCULE-6299186219, 3,3',4',5,5',7-hexOH-Flavone, Cannabiscetin solution, 20 mM in DMSO, 3,3 ,4 ,5,5 ,7-Hexahydroxyflavone, Flavone,3',4',5,5',7-hexahydroxy-, NCGC00015697-01, NCGC00015697-02, NCGC00015697-03, NCGC00015697-04, NCGC00015697-05, NCGC00015697-06, NCGC00015697-07, NCGC00015697-08, NCGC00015697-09, NCGC00015697-10, NCGC00015697-11, NCGC00015697-12, NCGC00015697-13, NCGC00094083-01, NCGC00094083-02, NCGC00094083-03, NCGC00094083-04, NCGC00179517-01, NCGC00179517-02, NCGC00261425-01, 4CN-1085, AJ-46397, AK111247, BC201817, CAS-529-44-2, HY-15097, LS-69005, NCI60_003870, ST057235, AB0149714, AX8140581, TR-018746, EU-0100740, FT-0672573, M2131, N1850, ST24041172, C10107, M 6760, M-1214, S00115, 3,3',4',5,5',7-hexahydroxy-(8CI)- flavone, 529M442, A829320, C07E0ED2-ABF6-4BD3-A2B2-A98CAEF20FD1, Myricetin, primary pharmaceutical reference standard, SR-01000076005-1, SR-01000076005-6, BRD-K43149758-001-04-5, I14-19097, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-1-benzopyran-4-one, 3,5,7-Trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one #, 3,5,7-tris(oxidanyl)-2-[3,4,5-tris(oxidanyl)phenyl]chromen-4-one, 4H-1-Benzopyran-4-one,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, 2-(3,4,5-TRIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-4H-1-BENZOPYRAN-4-ONE, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one solution, 20 mM in DMSO, 4H-1-Benzopyran-4-one, 3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)- (9CI)